Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulla Feldt-Rasmussen

Showing results (251-260 of 342) with videos related to

Pageof 35
Sort By:
The Journal of Clinical Endocrinology and Metabolism|May 10, 2007
Clinical implications of residual growth hormone (GH) response to provocative testing in adults with severe GH deficiencyGeorg Brabant, Ase Krogh Rasmussen, Beverly M K Biller, et al.
Pituitary|July 18, 2021
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV studySusan L Samson, Feng Gu, Ulla Feldt-Rasmussen, et al.
JIMD Reports|May 17, 2017
Improvement of Fabry Disease-Related Gastrointestinal Symptoms in a Significant Proportion of Female Patients Treated with Agalsidase Beta: Data from the Fabry RegistryWilliam R Wilcox, Ulla Feldt-Rasmussen, Ana Maria Martins, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2021
Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based StudyAndreas Ebbehoj, Kirstine Stochholm, Sarah Forslund Jacobsen, et al.
Thyroid : Official Journal of the American Thyroid Association|May 23, 2013
Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statementFrederik A Verburg, Markus Luster, Cristina Cupini, et al.
European Journal of Endocrinology|September 8, 2017
Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritisStina Willemoes Borresen, Marianne Klose, Bo Baslund, et al.
European Journal of Endocrinology|September 24, 2009
Narrow intra-individual variation of maternal thyroid function in pregnancy based on a longitudinal study on 132 womenMalene Boas, Julie Lyng Forman, Anders Juul, et al.
Molecular Genetics and Metabolism|October 5, 2020
Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT studyUlla Feldt-Rasmussen, Derralynn Hughes, Gere Sunder-Plassmann, et al.
Molecular Genetics and Metabolism|November 11, 2018
The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of expertsDominique P Germain, Michael Arad, Alessandro Burlina, et al.
Trials|April 11, 2014
The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trialKristian Hillert Winther, Torquil Watt, Jakob Bue Bjørner, et al.
Pageof 35

Showing results (251-260 of 342) with videos related to

Sort By:
Pageof 35
The Journal of Clinical Endocrinology and Metabolism|May 10, 2007
Clinical implications of residual growth hormone (GH) response to provocative testing in adults with severe GH deficiencyGeorg Brabant, Ase Krogh Rasmussen, Beverly M K Biller, et al.
Pituitary|July 18, 2021
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV studySusan L Samson, Feng Gu, Ulla Feldt-Rasmussen, et al.
JIMD Reports|May 17, 2017
Improvement of Fabry Disease-Related Gastrointestinal Symptoms in a Significant Proportion of Female Patients Treated with Agalsidase Beta: Data from the Fabry RegistryWilliam R Wilcox, Ulla Feldt-Rasmussen, Ana Maria Martins, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2021
Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based StudyAndreas Ebbehoj, Kirstine Stochholm, Sarah Forslund Jacobsen, et al.
Thyroid : Official Journal of the American Thyroid Association|May 23, 2013
Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statementFrederik A Verburg, Markus Luster, Cristina Cupini, et al.
European Journal of Endocrinology|September 8, 2017
Adrenal insufficiency is seen in more than one-third of patients during ongoing low-dose prednisolone treatment for rheumatoid arthritisStina Willemoes Borresen, Marianne Klose, Bo Baslund, et al.
European Journal of Endocrinology|September 24, 2009
Narrow intra-individual variation of maternal thyroid function in pregnancy based on a longitudinal study on 132 womenMalene Boas, Julie Lyng Forman, Anders Juul, et al.
Molecular Genetics and Metabolism|October 5, 2020
Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT studyUlla Feldt-Rasmussen, Derralynn Hughes, Gere Sunder-Plassmann, et al.
Molecular Genetics and Metabolism|November 11, 2018
The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of expertsDominique P Germain, Michael Arad, Alessandro Burlina, et al.
Trials|April 11, 2014
The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trialKristian Hillert Winther, Torquil Watt, Jakob Bue Bjørner, et al.
Pageof 35